International Congress on Neurology & Brain Disorders
- Dubai, UAE
We consider it a privilege and a matter of great pride to host the International Conference on Neurology and Brain Disorders on November 12-14, 2019 at Dubai, UAE. The conference will provide a forum for interaction among attendees on Leading World Doctors, registered Nurses, Professors, Research fellows and many more from leading universities, companies and medical research institutions, hospitals sharing their novel researches in the arena of Neurology. This event will create an interface among professionals, academicians and experts in the fields of Neurology and Brain Disorders.
This global meeting will together with the world leaders in the expanding fields related to Leading World Doctors, Registered Nurses, Professors, Research fellows and many more from leading universities, companies and medical research institutions, hospitals sharing their novel researches in the arena of Neurology and Brain Disorders. Thus, it is timely that this meeting will enable you to meet and discuss critical issues.
The present efforts to hold the IMPACT Neurology 2019 Conference in Dubai, UAE is based on our decision to involve Global academic faculty members, Health Care representatives, and students, researchers. In this mega event in Dubai, representatives in both industry and academia work with us to create a more interactive association in the field of Neurology and Brain Disorders.
The IMPACT Neurology 2019 Conference is a hub that covers the core aspects of neurology including "Neurological Rehabilitation, Translational Neuroscience, Interdisciplinary Neuroscience, Endovascular Neurosurgery, Molecular and Translational Neuroscience, Advanced Physiotherapy, Neurosciences and Neurological Disorders, Child Neurology, Brain and Cognitive Sciences, Applied Cognition and Neuroscience, Pain Science and Management, Neurorehabilitation, Clinical and Developmental"
We cordially invite you to participate in the conference by presenting your work as either talks or posters based on the themes identified above. We hope that you will take advantage of this unique opportunity to interact with eminent scholars, researchers, practitioners and industry representatives from throughout the world whose focus is to develop new and effective drugs to improve world health.
Neuroscience involves use of various methods to measure and image the brain activity. Neuroscience is umbrella term focusing on molecular, cellular, developmental, structural, functional, evolutionary, computing, psychosocial, and medical aspects of the nervous system. Research in neuroscience is constantly evolving based on biology, pharmaceutical science, medicine, cognitive science, and biomedical engineering. Neuroscience-based devices help in collecting valuable information regarding activities in brain and can be used in various areas such as better understanding of pathophysiology and symptoms of various chronic neurological diseases such as epilepsy, Alzheimer's disease and other dementias; cerebrovascular diseases including stroke, migraine, and other headache disorders, multiple sclerosis, Parkinson's disease, neuro-infections, brain tumors; and traumatic disorders of the nervous system due to head trauma.
These devices consist of different instruments that are required for neuroscience-based experiments. Various types of electrophysiology instruments and imaging instruments are utilized to map the brain and examine the brain activity.
The global neuroscience market size was valued at US$ 26,593 million in 2017, and is expected to witness a CAGR of 3.9% over the forecast period (2018-2026).
Increasing burden of neurological diseases worldwide is expected to be a major factor accelerating the growth of the global neuroscience market
Increasing prevalence of various chronic neurological diseases worldwide is expected to be a major driver for growth of the global neuroscience market. This is owing to high unmet medical need in terms of timely diagnosis and effective treatment of neurological diseases. This in turn requires better understanding of pathophysiology of the diseases and improvement in knowledge about functioning of nervous system, which is expected to boost demand for neuroscience devices.
According to World Alzheimer Report in 2016, around 46.5 million people suffered from Alzheimer's disease and the number was expected to reach 50 million by 2017, with a frequency of one new patient of Alzheimer's disease every there seconds worldwide.
According to World Health Organization (WHO) 2016 report, around 6 million deaths occur due to stroke, annually and over 80% of these deaths take place in low- and middle-income countries. Moreover, over 50 million people suffer from epilepsy and 47.5 million people from dementia, with 7.7 million new cases, annually worldwide.
However, product recalls by key players is expected to hinder the market growth. For instance, in 2017, Codman announced voluntary recall of CERTAS programmable valve in stock at hospitals and medical facilities based on a very small percentage of possible cases where the valve setting could change after an MRI procedure, or a problem could arise when trying to use the hand-held programming tool.
Increasing product launch and government funding for neuroscience research is expected to propel the neuroscience market growth
Key players in the market are focused on launching new instruments and software components, which address current research needs for neuroscience. This in turn is expected to boost the market growth. For instance, in 2015, Blackrock Microsystems LLC showcased new digital, wireless brain-interface titled-CerePlex W-at Society for Neuroscience Conference (SfN), Washington, U.S.
Furthermore, increasing government funding for research in the field of neuroscience is also expected to propel the market growth. For instance, in 2013, the U.S. government announced the BRAIN initiative (Brain Research through Advancing Innovative Neurotechnologies), which has the mandate of developing a host of tools to study brain activity.